Biosimilar Drugmakers Could Suffer From Trade Pact Changes

September 5, 2018

The most recent changes to the trade agreement between the U.S. and Mexico flies in the face of the Trump administration’s promises to lower drug prices, the country’s biggest generic drug association said.

Related Stories